Affinity Asset Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.22M | Sell |
|
|||||
|
2025
Q1 | $11.7M | Buy |
|
|||||
|
2024
Q4 | $6.35M | Sell |
|
|||||
|
2024
Q3 | $7.19M | Hold |
|
|||||
|
2024
Q2 | $6.44M | Sell |
|
|||||
|
2024
Q1 | $11.2M | Buy |
|
|||||
|
2023
Q4 | $3.98M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $898K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.69M | Buy |
|
|||||
|
2021
Q1 | $566K | Hold |
|
|||||
|
2020
Q4 | $815K | Buy |
|